Condition
MSS Metastatic Colorectal Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 MSS Metastatic Colorectal Cancer clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Adding pelareorep to FOLFIRI and bevacizumab for second-line RAS‑mutated, MSS metastatic colorectal cancer
This trial tests whether adding the oncolytic virus pelareorep to standard FOLFIRI plus bevacizumab helps people with RAS‑mutated, microsatellite‑stable metastatic colorectal cancer who progressed after first‑line oxaliplatin therapy.
-
Combining Fruquintinib, Adebrelimab, and Radiotherapy for Advanced Colorectal Cancer
This study is testing a new treatment that combines Fruquintinib, Adebrelimab, and radiotherapy to see if it can help people with advanced colorectal cancer who haven't responded to other treatments.
Related topics
Quick answers
How many MSS Metastatic Colorectal Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.